🔎 Trials Near Me

Akèy › Maladi selil fòs › Pennsylvania

Etid klinik pou Maladi selil fòs nan Pennsylvania

20 etid pou Maladi selil fòs ap chèche patisipan nan sit nan Pennsylvania.

Vil nan Pennsylvania

Tèks ofisyèl etid la (Anglè)

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

  • Spoknwrdclinicaltrials, Easton
  • Thomas Jefferson University Me, Philadelphia
Ap rekriteFaz 3
Laj 12 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06439082

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • University of Pittsburgh Medical Center (UPMC), Pittsburgh
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07187973

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Children's Hosptl Philadelphia, Philadelphia
  • St Christopher Hosp for Child, Philadelphia
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06612268

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  • Childrens Hospital Of Philadelphia, Philadelphia
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 12 a 55 · Tout sèks · Mizajou Sep 9, 2026 · NCT06546670

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Local Institution - 0029, Philadelphia
  • Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
  • Local Institution - 0032, Pittsburgh
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Children's Hospital of Philadelphia, Philadelphia
  • Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
  • St. Christopher's Hospital for Children, Philadelphia
  • ak 1 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • University of Pittsburgh, Pittsburgh
  • Hillman Cancer Center, Pittsburgh
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT06699849

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Ap rekriteFaz 1/2
Laj 5 a 40 · Tout sèks · Mizajou Aug 13, 2026 · NCT03653338

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteFaz 1/2
Laj 12 a 45 · Tout sèks · Mizajou Jun 4, 2026 · NCT07252050

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Children's Hospital of Philadelphia (MRD-HCT), Philadelphia
Ap rekriteEtid obsèvasyon
Laj 3 a 20 · Tout sèks · Mizajou Jun 4, 2026 · NCT06941389

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteFaz 4
Laj 18 a 50 · Fanm · Mizajou May 28, 2026 · NCT06665997

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekrite
Laj 13 a 21 · Tout sèks · Mizajou May 11, 2026 · NCT06290401

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

  • Children's Hospital of Philadelphia, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Ap rekriteFaz 2
Laj 15 a 40 · Tout sèks · Mizajou Mar 13, 2026 · NCT06260891

Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease

  • University of Pennsylvania, Philadelphia
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 27, 2026 · NCT07316478

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 14 a 37 · Tout sèks · Mizajou Jan 28, 2026 · NCT07373639

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Ap rekriteEtid obsèvasyon
2 Months – 60 Years · Tout sèks · Mizajou Jan 13, 2026 · NCT04528355

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • UPMC University of Pittsburgh Classical Hematology Adult Clinic, Pittsburgh
  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Ap rekrite
Laj 16 a 30 · Tout sèks · Mizajou Jan 7, 2026 · NCT06374238

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

  • UPMC Children's Hospital of Pittsburgh, Pittsburgh
Ap rekriteFaz 2
2 Months – 55 Years · Tout sèks · Mizajou Dec 15, 2025 · NCT01962415

Cutaneous Hydration Assessment in SCD

  • UPMC Sickle Cell Clinic, Pittsburgh
Ap rekrite
Laj 12 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05210114

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • University of Pennsylvania, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2025 · NCT06385886

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.